New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The Phase 1 clinical study is expected to enroll approximately 24 healthy adult volunteers. The primary objectives of the study are to characterize the pharmacokinetic release profile of the nalmefene ...

The trial plans to enrol around 700 adults with CIC, with the primary endpoint assessing patient-reported constipation ...

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...

Maze Therapeutics, a clinical-stage biopharmaceutical company, announced the dosing of the first patient in its Phase 2 clinical trial, the HORIZON Study, which is investigating MZE829, an oral APOL1 ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...

SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...

Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027. Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be rep ...

Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...